Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Organ Failure Prevention in Severe Acute Pancreatitis
NCT02691598Phase 4Unknown
- Sponsor
- Nanjing University School of Medicine
- Start
- Feb 2016
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute pancreatitis (AP) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Incidence rate of Organ failure at 30 days. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02691598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691598.